Nyxoah SA (NYXH) vs OraSure Technologies, Inc. (OSUR)

Nyxoah SA and OraSure Technologies, Inc. are both Medical Instruments & Supplies companies. OraSure Technologies, Inc. is the larger, with a market value of $262.8M against $121.2M — 2.2× the size. Nyxoah SA grew revenue faster over the last twelve months: 366.2% against −18.9%. OraSure Technologies, Inc. has the higher net margin (−43.7% vs −446.4%) and the higher return on invested capital (−21.5% vs −117.8%). Across the 18 metrics below, OraSure Technologies, Inc. leads on 11 and Nyxoah SA on 7.

Valuation

Metric NYXH OSUR Medical Instruments & Supplies median
P/E n/m n/m 33.75
P/S 2.52 2.22 2.52
P/B 0.65 0.78 2.48
Price to free cash flow n/m n/m 25.19
EV/EBITDA n/m n/m 14.62
EV/Sales 0.75 0.79 2.88
Earnings yield (227.03%) (19.11%) (2.67%)
Free cash flow yield (136.70%) (19.60%) 0.09%

Profitability

Metric NYXH OSUR Medical Instruments & Supplies median
Gross margin 60.16% 42.58% 54.29%
Operating margin (391.25%) (48.06%) 1.07%
Net margin (446.39%) (43.70%) (1.61%)
Free cash flow margin (344.99%) (43.44%) 1.08%
Return on equity (124.41%) (14.07%) (1.32%)
Return on assets (68.23%) (12.20%) 0.00%
Return on invested capital (117.82%) (21.46%) 0.00%

Growth

Metric NYXH OSUR Medical Instruments & Supplies median
Revenue growth (TTM) 366.24% (18.86%) 8.85%
EPS growth (last fiscal year) (36.22%) (261.54%) 8.65%
Revenue growth, 5-year CAGR 170.14% (7.70%) 9.17%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NYXH OSUR Medical Instruments & Supplies median
Debt to equity 0.72 0.00 0.10
Current ratio 2.38 8.88 2.48
Net debt to EBITDA 0.08 3.22 0.89

Dividend

Metric NYXH OSUR Medical Instruments & Supplies median
Dividend yield — — 1.11%
Payout ratio — — 0.27

Size

Metric NYXH OSUR Medical Instruments & Supplies median
Market cap 121.19m 262.77m 619.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack